Its exciting that we have medications that can help people who have obesity-related health conditions to lose weight and improve their health, but we still dont know all the ways in which they work. These results are important because they add to the growing body of evidence that GLP-1 medications work in a variety of ways to target the underlying causes of obesity, including taste perception, she notes
A 2022 study following 327 patients one year after discontinuing semaglutide treatment found that participants regained an average of two-thirds of the weight lost during treatment [5]
For researchers who lack access to a -20 degree freezer, short-term refrigerator storage at 2 to 8 degrees Celsius works for lyophilized product that will be used within a few months, though the stability window is shorter than deep-freeze storage
Nonetheless, individual patient factorsincluding age, sex, baseline bone health, nutritional status, and the extent of weight lossmay influence skeletal outcomes
The two pharmaceutical leaders in this space Novo Nordisk and Eli Lilly have seen astonishing growth in sales of their GLP-1 drugs for diabetes and obesity and have struggled to keep up with demand even at premium prices